MiR-145 Inhibits Oral Squamous Cell Carcinoma (OSCC) Cell Growth by Targeting C-Myc and Cdk6

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2013 May 29

PMID 23710609

Citations 60

Authors

Yuan Shao

Yiping Qu

Siwen Dang

Bowen Yao

Meiju Ji

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNAs (miRNAs) are a large group of negative gene regulators that potentially play a critical role in tumorigenesis. Increasing evidences indicate that miR-145 acts a tumor suppressor in numerous human cancers. However, its role in oral carcinogenesis remains poorly defined. The aim of this study is to determine expression levels of miR-145 in oral squamous cell carcinomas (OSCCs) and normal mucosa tissues, and explore its biological functions in OSCCs.

Methods: Reverse transcription quantitative real-time PCR (RT-qPCR) assay was used to evaluate expression levels of miR-145. The biological functions of miR-145 were determined by cell proliferation and colony formation, cell cycle and apoptosis, as well as cell invasion assay.

Results: MiR-145 was frequently down-regulated in OSCCs compared with normal mucosa tissues. Restoring miR-145 expression in OSCC cells dramatically suppressed cell proliferation and colony formation, and induced G1 phase arrest and cell apoptosis. Importantly, our data showed that miR-145 downregulated the expression of c-Myc and Cdk6, which have previously been identified as two direct targets of miR-145.

Conclusions: Our data suggest that miR-145 exerts its tumor suppressor function by targeting c-Myc and Cdk6, leading to the inhibition of OSCC cell growth. MiR-145 rescue may thus be a rational for diagnostic and therapeutic applications in OSCC.

Citing Articles

The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p.

Armstrong L, Willoughby C, McKenna D Int J Mol Sci. 2024; 25(8).

PMID: 38673886 PMC: 11050364. DOI: 10.3390/ijms25084301.

Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance.

Belnap C, Divis T, Kingsley K, Howard K Int J Mol Sci. 2024; 25(4).

PMID: 38396844 PMC: 10889714. DOI: 10.3390/ijms25042167.

Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities.

Vastrad S, Ritesh G, S V S, Saraswathy G, Augustine D, Alzahrani K Front Oncol. 2024; 13:1247399.

PMID: 38170015 PMC: 10759990. DOI: 10.3389/fonc.2023.1247399.

Expression of miR-145 and miR-18b in Peripheral Blood Samples of Head and Neck Cancer Patients.

Yadav A, Singh N, Yadav S, Bhatt M, Pandey A, Yadav D Indian J Clin Biochem. 2023; 38(4):528-535.

PMID: 37746533 PMC: 10516845. DOI: 10.1007/s12291-023-01119-2.

MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell Carcinoma.

Nakashiro K, Tokuzen N, Saika M, Shirai H, Kuribayashi N, Goda H Cancers (Basel). 2023; 15(16).

PMID: 37627167 PMC: 10452613. DOI: 10.3390/cancers15164138.

References

Ostenfeld M, Bramsen J, Lamy P, Villadsen S, Fristrup N, Sorensen K . miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene. 2009; 29(7):1073-84. DOI: 10.1038/onc.2009.395. View

Xu Q, Liu L, Qian X, Chen Q, Jiang Y, Li D . MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2011; 40(2):761-74. PMC: 3258133. DOI: 10.1093/nar/gkr730. View

Akao Y, Nakagawa Y, Naoe T . MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 2007; 26(5):311-20. DOI: 10.1089/dna.2006.0550. View

Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S . p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A. 2009; 106(9):3207-12. PMC: 2651330. DOI: 10.1073/pnas.0808042106. View

Yu T, Wang X, Gong R, Li A, Yang S, Cao Y . The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res. 2009; 28:64. PMC: 2687417. DOI: 10.1186/1756-9966-28-64. View

Kent O, Chivukula R, Mullendore M, Wentzel E, Feldmann G, Lee K . Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev. 2010; 24(24):2754-9. PMC: 3003192. DOI: 10.1101/gad.1950610. View

Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T . Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 2007; 98(12):1914-20. PMC: 11158757. DOI: 10.1111/j.1349-7006.2007.00618.x. View

Dang C . c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1998; 19(1):1-11. PMC: 83860. DOI: 10.1128/MCB.19.1.1. View

de Nigris F, Sica V, Herrmann J, Condorelli G, Chade A, Tajana G . c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle. 2003; 2(4):325-8. View

10.

Sridhar J, Akula N, Pattabiraman N . Selectivity and potency of cyclin-dependent kinase inhibitors. AAPS J. 2006; 8(1):E204-21. PMC: 2751441. DOI: 10.1208/aapsj080125. View

11.

Lee R, Ambros V . An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001; 294(5543):862-4. DOI: 10.1126/science.1065329. View

12.

Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K . Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer. 2009; 125(2):345-52. DOI: 10.1002/ijc.24390. View

13.

Zhu H, Dougherty U, Robinson V, Mustafi R, Pekow J, Kupfer S . EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res. 2011; 9(7):960-75. PMC: 3819602. DOI: 10.1158/1541-7786.MCR-10-0531. View

14.

Speranza M, Frattini V, Pisati F, Kapetis D, Porrati P, Eoli M . NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget. 2012; 3(7):723-34. PMC: 3443255. DOI: 10.18632/oncotarget.547. View

15.

Villadsen S, Bramsen J, Ostenfeld M, Wiklund E, Fristrup N, Gao S . The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer. 2011; 106(2):366-74. PMC: 3261682. DOI: 10.1038/bjc.2011.520. View

16.

Suh S, Chen Y, Zaman M, Hirata H, Yamamura S, Shahryari V . MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis. 2011; 32(5):772-8. PMC: 3086703. DOI: 10.1093/carcin/bgr036. View

17.

Iorio M, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P . MicroRNA signatures in human ovarian cancer. Cancer Res. 2007; 67(18):8699-707. DOI: 10.1158/0008-5472.CAN-07-1936. View

18.

Ambros V . microRNAs: tiny regulators with great potential. Cell. 2002; 107(7):823-6. DOI: 10.1016/s0092-8674(01)00616-x. View

19.

Leemans C, Braakhuis B, Brakenhoff R . The molecular biology of head and neck cancer. Nat Rev Cancer. 2010; 11(1):9-22. DOI: 10.1038/nrc2982. View

20.

Xu N, Papagiannakopoulos T, Pan G, Thomson J, Kosik K . MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009; 137(4):647-58. DOI: 10.1016/j.cell.2009.02.038. View